Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Claudio, Ridolfi"'
Autor:
Caterina Gianni, L Menghini, T Emiliano, Valentina Arcangeli, Lorenzo Gianni, D Samorani, Claudio Ridolfi, D Tassinari, L Stocchi
Publikováno v:
Cancer Research. 78:P3-11
Background. Treatment options for patients with hormone receptor positive metastatic breast cancer (MBC) and prior treatment with aromatase inhibitors (AIs) include EE or PF. To date no direct comparison has been presented between EE and Fulvestrant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc6b5ef1d6ad80972d2d2af4e7c0e3a0
https://doi.org/10.1158/1538-7445.sabcs17-p3-11-05
https://doi.org/10.1158/1538-7445.sabcs17-p3-11-05
Autor:
Emiliano Tamburini, Davide Tassinari, Lorenzo Gianni, Britt Rudnas, Claudio Ridolfi, Stefania Nicoletti, Fabrizio Drudi, Carlotta Santelmo
Publikováno v:
Critical Reviews in Oncology/Hematology. 104:115-123
In stage IV colorectal cancer, bevacizumab-based maintenance therapy, complete stop therapy and continuous therapy are considered all possible approaches after first line induction chemotherapy. However, there are no clear data about which approach i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::137ec44a83e6c5f270955d8ac42953ca
https://doi.org/10.1016/j.critrevonc.2016.05.016
https://doi.org/10.1016/j.critrevonc.2016.05.016
Autor:
Lorenzo Gianni, Claudio Ridolfi, Alessandra Affatato, Eleonora Barzotti, Fabrizio Drudi, Carlotta Santelmo, Alberto Ravaioli, Valentina Arcangeli, Manuela Fantini
Publikováno v:
Journal of Cancer Therapy. :777-781
Triple negative breast cancer (TNBC) is characterized by a high sensitivity to antiblastic drugs and a high pathological complete remission rate after neoadjuvant therapy. In patients showing complete remission, the probability of developing metastat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c218dfd357b657592229c90ea0ee435c
https://doi.org/10.4236/jct.2012.325097
https://doi.org/10.4236/jct.2012.325097
Autor:
Davide Tassinari, Giusi Giacomini, Luca Frassineti Giovanni, Britt Rudnas, Claudio Ridolfi, L. Stocchi, Emiliano Tamburini, Manuela Fantini, Luisa Nicoletti Stefania Vittoria, Rossana Berardi, Stefano Cascinu, Carlotta Santelmo
Publikováno v:
Annals of Oncology. 28:iii117-iii118
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3a43f36b732587aed30dcacffa9f2e7
https://doi.org/10.1093/annonc/mdx261.329
https://doi.org/10.1093/annonc/mdx261.329
Autor:
Davide Tassinari, Emiliano Tamburini, C. Cherubini, Fabrizio Drudi, A. Venturi, Emanuela Bianchi, Giuseppe Pasini, Claudio Ridolfi, F. Montanari, S.L.V. Nicoletti, Manuela Fantini
Publikováno v:
Annals of Oncology. 28:vi20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1217b5d4d3f744112e1ec6f9383b51ca
https://doi.org/10.1093/annonc/mdx423.011
https://doi.org/10.1093/annonc/mdx423.011
Autor:
A. Polselli, Carlotta Santelmo, Giuseppe Pasini, Eleonora Barzotti, Claudio Ridolfi, Fabrizio Drudi, Alberto Ravaioli
Publikováno v:
Journal of Medical Case Reports
Journal of Medical Case Reports, Vol 7, Iss 1, p 29 (2013)
Journal of Medical Case Reports, Vol 7, Iss 1, p 29 (2013)
Introduction Uterine leiomyosarcoma is one of the most frequent uterine sarcomas. In the metastatic setting it is sensitive to doxorubicin, ifosfamide, gemcitabine, docetaxel and a few other drugs, but time to progression is generally short. For this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0244b907799eb3c1c282d8ae42a989b8
https://doi.org/10.1186/1752-1947-7-29
https://doi.org/10.1186/1752-1947-7-29
Autor:
Fabrizio, Drudi, Davide, Tassinari, Jacopo, Giuliani, Claudio, Ridolfi, Lorenzo, Gianni, Emiliano, Tamburini, Manuela, Fantini, Carlotta, Santelmo, Eleonora, Barzotti, Nadia, Lotti, Alberto, Ravaioli
Adjuvant therapy represents the gold standard treatment for radically resected pancreatic cancer. Results from randomized clinical trials confirmed the efficacy of adjuvant therapy for pancreatic cancer but did not define what is the "right choice" i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a6286c9d34fa094dde6343f24b3af7dc
http://hdl.handle.net/11585/191733
http://hdl.handle.net/11585/191733
Autor:
L.A. Lazzari Agli, Emiliano Tamburini, Davide Tassinari, Manuela Fantini, C. Cherubini, Emanuela Bianchi, Maximilian Papi, Claudio Ridolfi, L. Stocchi, Stefania Nicoletti, Carlotta Santelmo
Publikováno v:
Annals of Oncology. 27:iv7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8f4ba96b1d7c3cd2b0b01c9f09a4e9c
https://doi.org/10.1093/annonc/mdw332.12
https://doi.org/10.1093/annonc/mdw332.12
Autor:
Claudio Ridolfi, F. Montanari, L. Stocchi, Emanuela Bianchi, Giuseppe Pasini, Emiliano Tamburini, S.L.V. Nicoletti, C. Cherubini, Davide Tassinari, Carlotta Santelmo, Manuela Fantini
Publikováno v:
Annals of Oncology. 27:iv31
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f0b557cfdaf6073ee11c1d6dc3a579c
https://doi.org/10.1093/annonc/mdw334.08
https://doi.org/10.1093/annonc/mdw334.08
Autor:
V. Arcangeli, Carlotta Santelmo, M. Famtini, A. Polselli, Emiliano Tamburini, Stefania Nicoletti, Lorenzo Gianni, G. Drudi, M. Nicolini, L. Stocchi, Davide Tassinari, E. Barzotti, Claudio Ridolfi, Fabrizio Drudi
Publikováno v:
Annals of Oncology. 27:iv120
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8cc4981c6b4ad384f163591b51f34da
https://doi.org/10.1093/annonc/mdw345.46
https://doi.org/10.1093/annonc/mdw345.46